Description
Briefly about the product
Bifiform – a probiotic directed action.
Pharmacological action of
Pharmacotherapeutic group: MIBP-eubiotic
Pharmacological action of
Eubiotic. The strains of Enterococcus faecium and Bifidobacterium longum, which are part of the drug, are natural symbiotic bacteria that inhabit the digestive tract. The drug has a normalizing effect on the quantitative and qualitative composition of the intestinal microflora. The action is due to both the direct direct effect of the components included in the preparation (high antagonistic activity against pathogenic and conditionally pathogenic microorganisms), and indirectly – stimulation of the local intestinal immunity (activation of immunoglobulin A synthesis, induction of endogenous interferon synthesis).
Bifidobacterium longum has a high survival rate in the human intestine and a high growth rate. The inclusion in the preparation of apatogenic enterococcus Enterococcus faecium, which normally colonizes the small intestine, allows a positive effect on the condition and digestive functions of not only the large but also of the small intestine, especially in the presence of fermentative dyspepsia and flatulence.
Indications
– diarrhea caused by acute and exacerbation of chronic gastroenteritis, rotavirus infection
– antibiotic-associated diarrhea acute diarrhea sarcoidosis in the complex treatment of chronic gastrointestinal diseases such as colitis, irritable bowel syndrome and other gastrointestinal disorders of the functional origin of
– normalization of myc intestinal roflora, treatment and prevention of dysbacteriosis and maintenance of the immune system in children over 2 years of age and adults
– lactose intolerance
– as part of a comprehensive standard eradication therapy in patients with helicobacter infection.
Use during pregnancy and lactation
Use of the drug Bifiform during pregnancy and lactation is considered safe, because the drug is not absorbed and does not have a systemic effect.
Special instructions
Precautions: Do not exceed the maximum daily dose.
Influence on the ability to drive vehicles and control mechanisms
The drug does not affect the ability to drive a car and control mechanisms.
Ingredients
1 capsule Bifiform contains:
Active ingredients: Bifidobacterium longum (Bifidobacterium longum – at least 107 bacterial cells), Enterococcus facus 107 bacterial cells).
Excipients: gum, magnesium stearate, lactic acid sourdough, lactulose, anhydrous dextrose.
Dosage and administration of
In acute diarrhea, the drug should be taken 1 capsule 4 times a day until stool normalizes. Then, the drug should be continued at a dose of 2-3 capsules per day until the symptoms disappear completely.
To normalize the intestinal microflora and support the immune system, the drug is prescribed in a dose of 2-3 capsules per day for 10-21 days.
Patients with lactose intolerance are recommended to take the drug 1 capsule 3 times a day.
When carrying out eradication therapy, Bifiform is prescribed 2 capsules 2 times a day for two weeks from the first day of eradication therapy.
For children from 2 years old, 1 capsule 2-3 times a day. If the child cannot swallow the capsule, it must be opened and the contents mixed with a small amount of liquid.
Side effects
When used in recommended doses according to established indications, no side effects were detected.
Overdose
Overdose symptoms not previously reported. In case of significant excess of the recommended doses, medical supervision is advisable.
Storage conditions
In a dry place at a temperature not exceeding 25 ° C. Keep out of the reach of children.
Expiration
2 years.
Pharmacy terms
OTC
Dosage form
capsules
Appointment
For adults, Children over 2 years old
Indications
Colitis, Gastrointestinal infections caused by Helicobacter pylori, Intestinal infections, Enteritis, Dysbacteriosis, Diarrhea
Possible product names
Bifiform capsules 40 pcs.
